 Antiretroviral Information - September 6, 2008
|
Initial results from a study, looking at trends with HIV treatment from the viewpoint of the patient and physician, identify some of the mental and physical challenges to self-injectables. FUZEON presents unique challenges because it is the first self-injectable antiretroviral, whereas all other treatments are oral |
|
Nine million young people will receive HIV/AIDS awareness text messages. The U.N. Children's Fund (UNICEF) is launching its Nigerian campaign because it has the third highest number of people with the disease |
|
Nine million young people will receive HIV/AIDS awareness text messages. The U.N. Children's Fund (UNICEF) is launching its Nigerian campaign because it has the third highest number of people with the disease |
|
South Africa's health ministry denies accusations that it is not doing enough to fight HIV/AIDS. Recent comments attack the lack of speed and legislature in place to properly handle the need for HIV/AIDS relief |
|
Although many doctors remain skeptical, there is some rays of hope in the fight of the HIV virus according to details released in the August 13 edition of The Lancet. Researchers have discovered that the drug valproic acid (Depakote) may be able to reduce the pool of dormant HIV-infected cells in the body |
|